Showing results (331-340 of 528) with videos related to

Sort By:
Pageof 53
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Cell|August 18, 2015
Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteMasaru Kanekiyo, Wei Bu, M Gordon Joyce, et al.
Science Translational Medicine|June 3, 2026
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sitesDaniel L Moss, Jiaxuan Cheng, Peter W Krug, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2023
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesisKimberly A Dowd, Devika Sirohi, Scott D Speer, et al.
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
Frontiers in Immunology|June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A VirusesGwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
Pageof 53